The Slow Space in Chronic Obstructive Pulmonary Disease*

Briscoe, W. A.; Nash, Eleanor S.

doi:10.1111/j.1749-6632.1965.tb14239.x

Cited by 54 publications

(18 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…William Briscoe is believed to be the first person to use the term COPD in discussion at the 9th Aspen Emphysema Conference. This term became established and today we refer to COPD as the designation of this growing health problem (Briscoe and Nash 1965). …”

Section: Definitionsmentioning

confidence: 99%

The history of COPD

Petty¹

2006

International Journal of COPD

View full text Add to dashboard Cite

The evolution of knowledge concerning COPD and its components – emphysema, chronic bronchitis, and asthmatic bronchitis – covers 200 years. The stethoscope and spirometer became important early tools in diagnosis and assessment. Spirometry remains the most effective means of identification and assessment of the course of COPD and responses to therapy, and is grossly underused for this purpose. Knowledge of the pathogenesis, course and prognosis, and new approaches to therapy have dramatically improved our understanding of this important clinical entity. Smoking cessation improves the early course of disease. Long-term oxygen improves the length and quality of life in selected patients with hypoxemia. Surgery benefits a select few. Today, COPD is a steadily growing global healthcare problem, with increasing morbidity and mortality. Early identification and prevention, and treatment of emerging stages of disease through smoking cessation and a growing number of bronchoactive drugs promises to change the outcome.

show abstract

Section: Definitionsmentioning

confidence: 99%

The history of COPD

Petty¹

2006

International Journal of COPD

View full text Add to dashboard Cite

show abstract

“…It is worth noting that at this stage the definition of COPD was clinicoradiological 7. William Briscoe is believed to be the first person to use the term COPD in discussions at the 9th Aspen Conference8 and Sukumalchantra and Williams were one of the first groups of authors to publish data using the term COPD 9. Following these earlier works, the anatomic location of the primary lesion in COPD was shown to be the small airway and the basis of COPD pathology was suggested to be inflammation 10–12.…”

Section: Introductionmentioning

confidence: 99%

Exacerbation rate, health status and mortality in COPD – a review of potential interventions

Seemungal

Hurst²,

Wedzicha³

2009

COPD

182

129

View full text Add to dashboard Cite

COPD is prevalent in Western society and its incidence is rising in the developing world. Acute exacerbations of COPD, about 50% of which are unreported, lead to deterioration in quality of life and contribute significantly to disease burden. Quality of life deteriorates with time; thus, most of the health burden occurs in more severe disease. COPD severity and frequent and more severe exacerbations are all related to an increased risk of mortality. Inhaled corticosteroids (ICS) have similar effects on quality of life but ICS/long-acting bronchodilator combinations and the long-acting antimuscarinic tiotropium all improve health status and exacerbation rates and are likely to have an effect on mortality but perhaps only with prolonged use. Erythromycin has been shown to decrease the rate of COPD exacerbations. Pulmonary rehabilitation and regular physical activity are indicated in all severities of COPD and improve quality of life. Noninvasive ventilation is associated with improved quality of life. Long-term oxygen therapy improves mortality but only in hypoxic COPD patients. The choice of an inhaler device is a key component of COPD therapy and this requires more attention from physicians than perhaps we are aware of. Disease management programs, characterized as they are by patient centeredness, improve quality of life and decrease hospitalization rates. Most outcomes in COPD can be modified by interventions and these are well tolerated and have acceptable safety profiles.

show abstract

“…In the same year, the American Thoracic Society published the "Diagnostic Standards for Non-Tuberculous Respiratory Disease" (14). In the 1960s, Burrows, Fletcher, Heard, Jones, and Wootliff distinguished between the emphysematous and bronchial types of chronic airways obstruction (6), and the term "chronic obstructive pulmonary disease" coined by Briscoe was adopted widely (15). In 1977, Fletcher and Peto provided a description of the natural history of the disease (16).…”

Section: Natural History and Pathogenesismentioning

confidence: 99%

One Hundred Years of Chronic Obstructive Pulmonary Disease

Fishman

2005

Am J Respir Crit Care Med

View full text Add to dashboard Cite

The Slow Space in Chronic Obstructive Pulmonary Disease*

Cited by 54 publications

References 20 publications

The history of COPD

The history of COPD

Exacerbation rate, health status and mortality in COPD – a review of potential interventions

One Hundred Years of Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About

The Slow Space in Chronic Obstructive Pulmonary Disease*

Cited by 54 publications

References 20 publications

The history of COPD

The history of COPD

Exacerbation rate, health status and mortality in COPD &ndash; a review of potential interventions

One Hundred Years of Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About

Exacerbation rate, health status and mortality in COPD – a review of potential interventions